Who Really Controls Your NHS Medical Records?

Millions of people across England may never have heard of the software platform quietly operating behind parts of the NHS, but a government review of a major contract has reignited questions about who controls patient information and what could happen to it in the years ahead.

At the centre of the debate is Palantir, the US technology giant that secured a £330 million contract to help run the NHS Federated Data Platform. While supporters argue the system has helped improve efficiency and reduce waiting lists, critics warn the wider implications for personal medical records deserve much greater scrutiny.

For residents in Newcastle and across the North East, the discussion goes far beyond technology. It touches on deeply personal issues including healthcare privacy, the future use of patient information, and whether sensitive data could one day influence decisions involving benefits, insurance, employment, or access to services.

The government's decision to review the contract ahead of a key break clause in 2027 has therefore become more than a routine procurement exercise. It has become a debate about who ultimately benefits from one of the largest collections of health data in the world.

Why NHS Data Is So Valuable.

Health records are among the most sensitive forms of personal information any individual possesses.

Unlike a password or bank card, medical history cannot simply be changed if it falls into the wrong hands. Records can reveal physical illnesses, mental health conditions, disabilities, medication use, family history, lifestyle habits, and long-term vulnerabilities.

According to NHS England, the NHS serves more than 56 million patients in England. That makes the health service one of the world's largest repositories of healthcare data.

Supporters of data-driven healthcare argue that analysing this information can help hospitals operate more efficiently, identify treatment trends, improve outcomes and reduce waiting times.

However, critics argue that the same data also represents an enormously valuable commercial asset.

Many privacy campaigners fear a future where patient information becomes increasingly attractive to private companies looking to develop products, train artificial intelligence systems or gain commercial advantages from insights generated through public healthcare systems.

Questions Over Who Benefits From NHS Patient Information.

Several technology and healthcare experts have welcomed the government's decision to reassess the Palantir arrangement.

Some argue that Britain possesses the expertise needed to build and manage its own healthcare data infrastructure rather than relying on overseas technology providers.

Their concern is not necessarily about whether Palantir's technology works. Instead, it focuses on whether valuable NHS knowledge and data-driven innovation should remain under British control.

Critics claim that when external companies gain access to large-scale health datasets, they are often able to develop expertise and products that can later be sold elsewhere.

The result, they argue, is that British taxpayers fund the creation of valuable healthcare intelligence while much of the commercial benefit flows overseas.

For cities like Newcastle, which already have strong links to medical research through Newcastle University and the region's healthcare innovation sector, some believe there is a missed opportunity to build home-grown solutions capable of creating jobs and investment locally.

Could Health Data Be Used Against People In The Future?

One of the most controversial aspects of the debate concerns future possibilities rather than current practices.

There is currently no evidence that NHS patient records are being used to determine benefit eligibility, employment decisions or insurance pricing through the Palantir platform.

However, privacy advocates argue that today's safeguards may not necessarily remain unchanged forever.

Their concern is rooted in a simple question: once enormous databases have been created and interconnected, what future governments or organisations might seek to do with them?

Campaigners often point to historical examples where technologies introduced for one purpose were later expanded into entirely different areas.

Some fear that individuals with long-term illnesses, disabilities, mental health conditions or chronic health problems could eventually face increased scrutiny if healthcare information becomes more interconnected with other government systems.

This concern becomes particularly sensitive when discussing the Department for Work and Pensions, benefit assessments, or future welfare reforms.

While no such integration has been proposed as part of the current NHS platform, critics argue that citizens should remain vigilant whenever large-scale personal data systems are developed.

Growing Public Unease About Data Sharing.

Public trust remains one of the NHS's most valuable assets.

Research by the National Data Guardian has repeatedly shown that patients generally support data being used to improve healthcare, provided it remains secure and transparent.

However, confidence can quickly erode when people feel they do not fully understand how information is being used.

A survey conducted by Understanding Patient Data found that many people support health data sharing for public benefit, but significantly fewer are comfortable when commercial interests become involved.

This distinction highlights a growing challenge facing policymakers.

Most patients understand the value of medical research and operational improvements. What worries many people is uncertainty over where the boundaries are drawn and whether those boundaries could shift over time.

The Statistics Behind Britain's Health Data Economy.

The scale of healthcare information generated within the NHS is staggering.

NHS Digital previously estimated that healthcare systems process millions of patient interactions every day.

Meanwhile, research from the Department for Science, Innovation and Technology has highlighted the growing economic value of health data, with the UK's wider data economy estimated to contribute hundreds of billions of pounds annually to economic activity.

Artificial intelligence has intensified interest further.

A 2025 report from the International Data Corporation predicted global spending on AI technologies would exceed $300 billion annually within the next few years.

Healthcare is expected to be one of the fastest-growing sectors for AI investment because of the vast quantities of information available for analysis.

For critics, these figures demonstrate why robust protections are essential.

The more valuable data becomes commercially, the greater the incentives for organisations to seek access to it.

Newcastle Residents Have Particular Reasons To Pay Attention.

Although the debate is national, it carries local significance across Newcastle and the wider North East.

The region has become increasingly recognised for health innovation, medical research and digital technology development.

Newcastle Hospitals NHS Foundation Trust serves hundreds of thousands of patients every year and plays an important role in medical research and specialist care.

As healthcare becomes more digitised, local residents have a direct stake in how patient information is stored, analysed and protected.

Many Newcastle families rely on NHS services throughout their lives, from maternity care and childhood treatment through to long-term management of chronic conditions.

For these individuals, questions surrounding healthcare data are not abstract policy discussions. They involve highly personal information that many people expect to remain confidential.

Government Review Could Shape The Future Of NHS Technology.

The government's review of the Palantir contract arrives at a crucial moment.

Officials will examine whether the arrangement continues to represent value for money and whether it aligns with wider healthcare objectives.

Supporters point to claimed improvements in hospital productivity and reductions in treatment delays.

Palantir has previously stated that implementation of its technology helped facilitate tens of thousands of additional procedures and improved performance in certain cancer referral pathways.

Yet opponents argue that efficiency alone should not determine the outcome.

They believe the review must also consider sovereignty, accountability, market competition and the long-term stewardship of NHS information.

The debate ultimately raises a broader question about the future direction of British public services in an increasingly data-driven world.

A Decision That Could Affect Future Generations.

The outcome of the review may influence far more than NHS procurement policy.

It could establish principles governing how Britain manages some of its most sensitive public data assets for decades to come.

Whether discussing healthcare records, future AI systems or digital government services, decisions made today will shape how personal information is treated tomorrow.

For many observers, the issue is no longer simply about one company or one contract.

It is about determining who controls public data, who profits from it, and how citizens can be protected as technology becomes increasingly embedded in everyday life.

As Newcastle residents and millions of others continue to share their personal information with healthcare providers, those questions are likely to become more important than ever.

Join The Discussion.

What private medical data would you be fine sharing with AI-based companies?